Correlation Between Monopar Therapeutics and ProPhase Labs
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and ProPhase Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and ProPhase Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and ProPhase Labs, you can compare the effects of market volatilities on Monopar Therapeutics and ProPhase Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of ProPhase Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and ProPhase Labs.
Diversification Opportunities for Monopar Therapeutics and ProPhase Labs
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Monopar and ProPhase is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and ProPhase Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProPhase Labs and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with ProPhase Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProPhase Labs has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and ProPhase Labs go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and ProPhase Labs
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 6.85 times more return on investment than ProPhase Labs. However, Monopar Therapeutics is 6.85 times more volatile than ProPhase Labs. It trades about 0.06 of its potential returns per unit of risk. ProPhase Labs is currently generating about -0.1 per unit of risk. If you would invest 470.00 in Monopar Therapeutics on September 1, 2024 and sell it today you would earn a total of 1,783 from holding Monopar Therapeutics or generate 379.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. ProPhase Labs
Performance |
| Timeline |
| Monopar Therapeutics |
| ProPhase Labs |
Monopar Therapeutics and ProPhase Labs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and ProPhase Labs
The main advantage of trading using opposite Monopar Therapeutics and ProPhase Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, ProPhase Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProPhase Labs will offset losses from the drop in ProPhase Labs' long position.| Monopar Therapeutics vs. Cue Biopharma | Monopar Therapeutics vs. Tff Pharmaceuticals | Monopar Therapeutics vs. Lantern Pharma | Monopar Therapeutics vs. Eliem Therapeutics |
| ProPhase Labs vs. Star Equity Holdings | ProPhase Labs vs. Enzo Biochem | ProPhase Labs vs. Neuronetics | ProPhase Labs vs. Intelligent Bio Solutions |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |